Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/KORU Medical Systems, Inc./ 10-Q

Quarterly Report · 10-Q

KORU Medical Systems, Inc.

KRMDNASDAQEQUITYCurrent

Quarterly Report

Filed Aug 5, 2026Accepted Aug 5, 2026, 4:08 PM EDTCIK 704440Accession 0001161697-26-000189
View company →Permanent SEC source ↗
Share

Company context

KORU Medical Systems develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions that improve quality of life for patients around the world. The Freedom Syringe Infusion System (the “Freedom System”) currently includes the Freedom60® and FreedomEDGE® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HigH-Flo Subcutaneous Safety Needle Sets™. The Freedom System, which received its first FDA clearance in 1994, is used for self-administration in the home by the patient and/or delivery in an ambulatory infusion center by a healthcare professional. Through its Pharma Service and Clinical Trials business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process and, as needed, is capable of customizing the Freedom System for clinical and commercial use across multiple drug categories. For more information, please visit www.korumedical.com.

Current securities

KRMDNASDAQ · EQUITY · Current
Historical securities (1)
REPROTC · EQUITY · Historical · closed Oct 17, 2019

Recent company filings

  1. 4 filingSep 9, 2026
  2. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearAug 14, 2026
  3. 4 filingAug 6, 2026
  4. Results of Operations and Financial ConditionAug 5, 2026
  5. 144 filingAug 3, 2026

Registered securities in this filing

KORU MEDICAL SYSTEMS, INC. · 10-Q · Filed 2026-08-05

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common stock, $0.01 par value

Symbol
KRMD
Exchange
NASDAQ
Classification
COMMON
Status
Current
Filing context

Context: From2026-01-01to2026-06-30

Dimensions: Not supplied

Accession 000116169726000189 · 1 registered-security cover member

Read the exact SEC filing ↗

As-filed source

Primary evidence
As filedOpen full document ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.